4.8 Article

Reversible lysine fatty acylation of an anchoring protein mediates adipocyte adrenergic signaling

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.2119678119

关键词

lysine myristoylation; signal transduction; adrenergic receptor; HDAC11

资金

  1. RockyMountain Neurological Disorders Core Grant [P30 NS048154]
  2. Diabetes Research Center [P30 DK116073]
  3. NSF Major Research Instrumentation [DBI-1337573]
  4. NIH Shared Instrument [S10 RR023381]
  5. Canadian Institutes of Health Research [FRN-216927]
  6. American Heart Association [829504, 18AIREA33960175, 16SFRN31400013]
  7. NIH Training Grant [T32HL007822]
  8. NIH [HL141963, HL116848, HL147558, DK119594, HL127240, HL150225]
  9. Robert J. Kleberg Jr. and Helen C. Kleberg Foundation

向作者/读者索取更多资源

This article highlights the importance of lysine myristoylation in regulating protein localization and function, as well as its role in controlling G protein-coupled receptor signaling. Inhibiting HDAC11 may have therapeutic potential for manipulating adipocyte phenotypes.
N-myristoylation on glycine is an irreversible modification that has long been recognized to govern protein localization and function. In contrast, the biological roles of lysine myristoylation remain illdefined. We demonstrate that the cytoplasmic scaffolding protein, gravin-alpha/A kinase-anchoring protein 12, is myristoylated on two lysine residues embedded in its carboxyl-terminal protein kinase A (PKA) binding domain. Histone deacetylase 11 (HDAC11) docks to an adjacent region of gravin-alpha and demyristoylates these sites. In brown and white adipocytes, lysine myristoylation of gravin-alpha is required for signaling via beta(2)- and beta(3)-adrenergic receptors (beta-ARs), which are G protein-coupled receptors (GPCRs). Lysine myristoylation of gravin-alpha drives beta-ARs to lipid raft membrane microdomains, which results in PKA activation and downstream signaling that culminates in protective thermogenic gene expression. These findings define reversible lysine myristoylation as a mechanism for controlling GPCR signaling and highlight the potential of inhibiting HDAC11 to manipulate adipocyte phenotypes for therapeutic purposes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据